Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

CIGB2020

Havana, Aug 12 (Prensa Latina) Cuba´s Center for State Control of medicines, Equipment and Medical Devices (CECMED) on Wednesday authorized the start of a phase-II clinical trial with the vaccine candidate CIGB2020, seeking to stimulate the immune response against acute respiratory infections.